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The rate of mitochondrial ATPase inactivation by the naturally occurring inhibitor protein in the presence 
of saturating ATP and Mgz+ at pH 8.0 depends hyperbolically on the amount of inhibitor added; the upper 
limit of an apparent first-order constant for the inactivation process is 1.0-l at 25°C. A dramatic difference 
in the inactivation rate is observed when the protein inhibitor is added to the same assay system from either 
acidic (pH 4.8) or alkaline (pH 8.2) solutions. The slow reversible transition of the inhibitor from its rapidly 
reacting ‘acidic’ form to the slow reacting ‘alkaline’ form occurs when the solution of the protein inhibitor 
is subjected to a pH-jump from 4.8 to 8.2 (tljz - 30 s at 25°C). The pH-profile of the inhibitor active/inactive 
equilibrium suggests that a group with p&w 6.5 is involved in the transition. Treatment of the inhibitor 
protein with a histidine-specilic reagent (e.g. diethyl pyrocarbonate) abolishes its inactivating effect on the 
ATPase activity. It is concluded that the protonation/deprotonation of the inhibitor protein followed by 
its slow conformational changes is the rate-limiting step in the inhibitor-ATP synthetase interaction. 
ATP synthetase Inhibitor protein 
1. INTRODUCTION 
The ATP hydrolytic activity of the mitochon- 
driaI ATP synthetase can be specifically abolished 
by the natural ATPase inhibitor (IFi) discovered 
by Pullman and Monroy [l] in preparations of 
beef heart mitochondrial coupling factor Fi. 
Subsequent studies (review [2]) have shown that 
IFi or similar low-Mr peptides are present in a 
number of membrane-bound ATP synthetase com- 
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Abbreviations: Fr, beef heart mitochondrial coupling 
factor; IFr, beef heart ATPase protein inhibitor; AS- 
particles, submitochondrial ultrasonic particles depleted 
of IF, by slow filtration through Sephadex; Mops, 3-(N- 
morpholino)propanesulphonate; Mes, 4-morpholineeth- 
anesulphonate; FCCP, carbonyl cyanide p-trifluoro- 
methoxyphenylhydrazone 
Acid-base transition Mitochondria 
plexes [3-61. An intriguing feature of IFi which is 
not clearly understood is that it inhibits the ATP 
hydrolytic activity of the soluble [1,7,8] or 
membrane-bound Fi [ 1,7- 121 and the ATP-driven 
processes in the coupling membranes [8,9,11,13] 
whereas the net oxidative phosphorylation is insen- 
sitive to the inhibitor [1,13-151. The hypothesis 
has been originally proposed [ 161 and further 
developed [ 17,181 on the ApH+-dependent 
dissociation/association of the IFi . Fi complex, 
which explains the apparently unidirectional in- 
hibition of the reversible H+-ATPase by IFi. The 
kinetics and thermodynamics of ATPase-IFi in- 
teraction have been extensively studied ([ 19,201 
and references cited therein), and a number of 
schemes which account for several complex 
features of the ATPase inhibition/reactivation 
have been proposed [10,17-211. 
Here we present data demonstrating an unusual 
property of the mitochondrial IFi, namely the slow 
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hysteretic pH-dependent interconversion between 
rapidly and slowly inhibiting forms of the protein. 
An immediate output of this finding is that the 
protonatio~/deprotonation of IFI followed by its 
slow conformation change is the rate-limiting step 
in the inhibitor-ATP synthetase interaction. 
2. MATERIALS AND METHODS 3. RESULTS AND DISCUSSION 
Bovine heart subm~toc~ondrial particles free of 
the protein ATPase inhibitor (AS-particles) were 
prepared essentially as described [22]. The particles 
were activated at 23°C by phosphate 123) for 
30 min in a mixture containing (final concentra- 
tions): IO mM Mops, 10 mM KC& 2 mM MgClz, 
50 FM EDTA, 0. I M sucrose and S mM potassium 
phosphate (pH 7.0). IFr was prepared by the 
method of Kanner et al. [24]. The ATPase activity 
was measured at 340 nm at 25°C in a reaction mix- 
ture containing (final concentrations): 10 mM 
Mops, 10 mM KGl, 2 mM MgCh, 50pM EDTA, 
0.1 M sucrose, 2.5 mM KHSU3, 2 mM KCN, 
10v6 M FCCP, 1 mM potassium phosphoenolpy- 
ruvate, 1 mM ATP/Mg2’“, 0,16 mM NAD * H, py- 
ruvate kinase (3.3 units per ml) and lactate de- 
hydrogenase (3.3 units per ml); pH is indicated in 
the figure legends. Sulphite was added to the assay 
mixture to avoid the time-dependent, ADP- 
specific inhib?tion of ATPase [25,26]. The 
Fig.I demonstrates the time course of ATP 
hydrolysis and inhibition of the reaction by an ex- 
cess of IFi. The patterns of inhibition are the same 
irrespective of whether the reaction is started by 
the particles and IFt is added during the steady- 
state hydrolysis, or IFr is present in the assay mix- 
ture before hydrolysis is initiated, As evident from 
the experiment documented by trace 3, the amount 
af IF1 is indeed in excess, since the same rate of in- 
hibition is observed when the second portion of 
AS-particles is added to the assay mixture after the 
inactivation of the first portion has been com- 
pleted. When the apparent first-order rate constant 
for the inhibition process was plotted as a functian 
af the inhibitor amount (fig.2, curve 1), a 
Fig.1. Time course of ATPase inhibition by IFr. The 
reaction was started by the addition of activated AS- 
particles (AS-p) (14 pgf to 1.5 ml of the standard assay 
mixture (see section 2) at pN 8.0. 16 pg fF1 dissolved in 
a mixture containing 50 mM sucrose, 5OpM EDTA, 
5 mM Tris, and 5 mM Mes (pW 8.2) were added to the 
assay cuvette during ATP hydrolysis (curve 2) or before 
the reaction was initiated (curve 3). Curve 1, no IFr 
present. The specific ATPase activity without added IFE 
was 2.3 pmoi ATP hydro~~~ed/min per mg protein. 
nucleotides (potassium salts), pyruvate kinase and 
lactate dehydrogenase were obtained from Reanal 
(Hungary). The enzymes were extensively dialyzed 
before use. Mops and Mes were obtained from 
Calbiochem; other chemicals were of the purest 
grade commercially available. 
Fig.2. Dependence of the inhibition apparent first-order 
rate constant on the amount of IF* added. Experimental 
conditions as in fig.1. Curve 1 (left ordinate), IFI was 
added to the assay mixture (pH 8.0) from the solution 
adjusted to pH 8.2. Curve 2 (right ordinate), IF1 was 
added to the assay mixture (pH 8.0) from the solution 
adjusted to pH 4.8. The pH changes in the assay mixture 
after additions of IFt were negligibte. 
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Fig.3. Time course of the pH-dependent active/inactive 
transitions of IFr. (A) The actual traces of the ATPase 
assays at pH 8.0 after addition of IFi. pH of the buffers 
where IF1 was dissolved was adjusted to 8.2 (curve 2) or 
4.8 (curve 3) and IF1 was added to the assay mixture (pH 
8.0) where indicated. The buffer containing IFi at pH 
4.8 was then rapidly adjusted to pH 8.2, and IFi was 
added to the assay mixture 15, 30 and 300 s after the pH 
jump (curves 4, 5 and 6, respectively); pH was then 
readjusted to 4.8 and 60 s later IFr was added to the 
assay mixture (curve 7). Curve 1, no IF1 added. (B) IFI 
saturating curve was obtained with an upper limit 
of 1.0 min-‘. In accordance with [I ,7], it was 
observed that the maximal rate of inhibition is 
strongly pH-dependent. At pH 6.0, the inhibition 
rate increases up to the level which does not permit 
an accurate determination of the first-order rate 
constant. Under these conditions (pH 6.0), the rate 
of the ATPase reaction itself is only slightly 
(-20%) decreased as compared with that at pH 
8.0, thus suggesting that the increase in inhibition 
rate is most probably due to a change of IFi rather 
than of Fi. 
An unexpected finding shown in fig.3A is that 
when equal amounts of IFI were added to ATP 
hydrolyzing particles from acidic or alkaline solu- 
tions of the inhibitor the inhibition patterns were 
quite different, i.e., acidic IFr almost instantly in- 
activates ATPase, whereas alkaline inhibitor slow- 
ly inhibits the reaction. The reversible transition 
from the rapidly reacting to the slowly reacting 
form of IF1 is slow enough to be registered at 25°C 
as shown in fig.3B. The transition is strongly 
temperature-dependent, indicating significant 
structural rearrangements which occur during the 
pH jump induced transformation (tr,z for inter- 
conversion of ‘active’ to ‘inactive’ IFI is about 30 s 
and 20 min at 25 and O”C, respectively). When the 
inhibition rate was plotted as a function of acidic 
IFi, a straight line was obtained (fig.2, line 2), in- 
dicating a simple second-order eaction between Fr 
and acidic IFr, which is a first-order process with 
respect to the inhibitor. 
The pH profile of the active/inactive inter- 
conversion of IFI (not shown) suggested the par- 
ticipation of a single group with an apparent pK, 
of 6.5. Although a straightforward interpretation 
was dissolved in the buffer (see legend to fig. 1) at pH 4.8 
and its inhibitory effect was estimated as the amount of 
ATP hydrolyzed by AS-particles during 1 min after the 
addition of IFi. At zero time, the pH of the IFI solution 
was adjusted to 8.2, and the inhibitory efficiency was 
measured as a function of time after the pH jump. 
Curves 1 and 2, the solutions where the proper amounts 
of IF1 for the assays were taken from were incubated at 
25 and O”C, respectively. The amounts of AS-particles 
and IF1 added to 1.5 ml of the assay mixture were 14 and 
16 lg, respectively. 
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Fig.4. Inactivation of IFi by a histidine-specifc reagent. 
14/cg AS-particles were preincubated at 25°C for the 
time indicated on abscissa in 200~1 of the buffer used 
for activation (see section 2) which contained 4pM 
ATP, 5 mM phosphoe~oZpyruvate, 10units of pyruvate 
kinase and 0.045 ,ug IF1 pretreated as described below. 
The ATPase activity was then assayed in the standard 
mixture made by the adjustment of the volume to 1.5 ml 
with the buffer containing all the necessary components. 
4.5 pg IF1 were preincubated at 25°C for 10 min in 
100,ul of a mixture cont~~ng 10 mM Mops, 10 mM 
KCl, 50 mM sucrose and 1 mM diethyl pyrocarbonate 
(pH 6.0). Aliquots of the mixture were added to the 
suspension of AS-particles, and the incubation was 
started as described above. Curve 1, no additions to AS- 
particles; curve 2, IFI preincubated without diethyl 
pyrocarbonate was added to AS-particles; curve 3, IFI 
treated with diethyl pyrocarbonate was added to AS- 
particles; curve 4, an aliquot containing diethyl 
pyrocarbonate without IFi was added to AS-particles. 
The IFI to IFi molar ratio in the incubation mixture was 
0.8. 100% corresponds to a specific activity of 2.3. 
of the pH-dependent equilibrium between the ac- 
tive and inactive IFr can hardly be made, an ap- 
parent pKa of 6.5 might indicate a histidine residue 
as a feasible participant of the process. Indeed, 
when IFr was treated with a histidine-specific 
reagent (diethyl pyrocarbonate), its inhibitory 
potency was lost (fig.4). 
The simplest model for the IFr-Fr interaction 
which accounts for the findings reported here as 
well as for other data reported in the literature may 
be formulated as follows. Apparently, a specific 
site exists in one of the intermediate Fr - substrate 
(product) complexes (presumably on the &subunit 
[12,27]), where IFI binds, thus inhibiting the ATP 
hydrolytic activity. The IF1 as prepared by conven- 
tional procedures [1,6,7,24,28,29] should be 
regarded as a denatured protein capable of slow 
spontaneous renaturation at acidic pH. It also 
renaturates at any given pH in the presence of ATP 
hydrolyzing Fr as a result of the inhibitor natural 
conformation stabilization within the ATP syn- 
thetase complex (e.g., at pH 8.0 the rate constant 
for renaturation is 1 min-‘; fig.2, curve 1). A very 
high sensitivity of IF1 to tryptic digestion [1,7] 
seems to be relevant to the proposed denatured 
state of the protein inhibitor preparations. The 
central finding of this report is that the pH- 
dependent structural changes of IF1 are slow as 
compared to the rate of the active IFr-FI interac- 
tion, and the kinetics of the inhibition are strongly 
dependent on the original state of the protein. This 
may cause serious errors in kinetic studies of the Fr 
inactivation/rea~tivation process. A more impor- 
tant, though less explicit implication of the model 
is that the slowly reversible denaturation/renatura- 
tion process should be taken into account, when 
the physiological ‘regulatory’ role of IFI is being 
considered [9,11,13,16,17]. At the moment, no 
clear-cut evidence exists for ASH+-dependent ac- 
tivation/deactivation of the ATP hydrolytic activi- 
ty of Fr synchronous with its ATP synthetase ac- 
tivity in submitochondrial particles, although some 
correlation between IFr release and phosphory- 
lating activity has been reported [14,17,18]. The 
experimentally supported hypothesis on two states 
of Fr (hydrolase and synthetase) [30-321 also 
seems relevant to the functional role of IFr. We 
believe that under physiological conditions IFI 
serves as a stabilizer of the Fr-synthetase state, thus 
preventing a possible leakage of the phosphory- 
lating potential of ATP in ~tochondria. 
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